These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4344560)

  • 1. [Course observations on 59 Fe bone marrow topography in the myeloproliferative process].
    Stephan G; Montz R; Treske U
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:29-30. PubMed ID: 4344560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polycythemia and splenomegaly in a 51-year-old woman].
    Ribera JM; Abella E; Lloreta J
    Med Clin (Barc); 1995 Jul; 105(5):191-6. PubMed ID: 7630233
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early diagnosis of proliferative bone-marrow diseases with radioactive iron].
    Montz R; Schneider C; Treske U
    Dtsch Med Wochenschr; 1972 Jun; 97(26):994-1000. PubMed ID: 5038802
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypocholesterolemia in myeloproliferative disorders.
    Spanos GA; Bajaj K; Rosner F
    Arch Intern Med; 1981 Jan; 141(1):137-8. PubMed ID: 6934710
    [No Abstract]   [Full Text] [Related]  

  • 7. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI; Vardiman JW
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT; Peterson P
    Prog Clin Biol Res; 1984; 154():19-42. PubMed ID: 6382293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue culture of bone marrow. 3. Myelostimulatory factors in serum of patients with myeloproliferative diseases.
    Reisner EH
    Cancer; 1967 Oct; 20(10):1679-88. PubMed ID: 5234302
    [No Abstract]   [Full Text] [Related]  

  • 12. Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, and laboratory findings.
    Kaplan KR; Mitchell DG; Steiner RM; Murphy S; Vinitski S; Rao VM; Burk DL; Rifkin MD
    Radiology; 1992 May; 183(2):329-34. PubMed ID: 1561331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytometric characteristics of erythrocytes in polycythemia vera].
    Kotsiubinskiĭ NN; Dygin VP; Koval' IuV
    Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):33-6. PubMed ID: 7045861
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual radiological findings in a case of myelofibrosis secondary to polycythemia vera.
    Sideris P; Tassiopoulos S; Sakellaropoulos N; Androulaki A; Variami E; Gogas H; Kanakis M; Vaiopoulos G
    Ann Hematol; 2006 Aug; 85(8):555-6. PubMed ID: 16673126
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract]   [Full Text] [Related]  

  • 16. Classification and evolution of patterns of erythropoiesis in polycythemia vera as studied by iron kinetics.
    Pollycove M; Winchell HS; Lawrence JH
    Blood; 1966 Dec; 28(6):807-29. PubMed ID: 5959474
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous involvement by post-polycythemia vera myelofibrosis.
    Pecci A; Croci G; Balduini CL; Boveri E
    Am J Hematol; 2014 Apr; 89(4):448. PubMed ID: 23877876
    [No Abstract]   [Full Text] [Related]  

  • 18. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM; Thiele J
    Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of histamine in myeloproliferative disease.
    Gilbert HS; Warner RR; Wasserman LR
    Blood; 1966 Dec; 28(6):795-806. PubMed ID: 5959473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.